You can buy or sell JAZZ and other stocks, options, and ETFs commission-free!
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland. The listed name for JAZZ is Jazz Pharmaceuticals plc Common Stock (Ireland).
Bruce C. Cozadd
52 Week High
52 Week Low
Canopy Growth Corp, GW Pharma, Jazz Pharmaceuticals - Item 9 Labs and Why Franchising is the Growth Vehicle to Propel the Cannabis Industry
Item 9 Labs Corp. is a sponsor and will speak at the Benzinga Cannabis Capital Conference set to take place on February 25-26, 2021. The information contained i
$4.20 per share
$4.00 per share